🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.
UPGRADE TO SEE LIVE SIGNALS
$NYKD.OL
Nykode Therapeutics ASA
FREE PREVIEW
📅 Next Earnings: May 27, 2026 🌙 Close🌐 Website🏛️ Euronext Oslo📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP0.00%
MAX GAP RECORD0.00%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY0.0%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway. Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL